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Introduction {#s1}
============

Mercury (Hg) is a well-characterized environmental toxicant with known adverse health outcomes worldwide ([@c30]). Hg is present in three different forms, which include elemental mercury \[(${Hg}^{0}$), inorganic mercury (mercury salts), and organic mercury (methyl mercury (MeHg)\]. The general population is exposed to a relatively low level of inorganic Hg, primarily through dental amalgam; inhalation from anthropogenic sources, such as metal mining and smelting; combustion of fossil fuels; and incineration of municipal wastes ([@c55]; [@c78]). Elevated exposure to inorganic Hg is found among mercury miners, gold miners, dentists, and patients receiving dental amalgams ([@c46]; [@c48]). Marine and freshwater fish consumption is the most common route of MeHg exposure for the general population ([@c18]). Many coastal and island dwellers frequently consume locally available marine seafood species that are high in MeHg. Some Indigenous populations also frequently consume traditional wild-caught marine foods, including top predators such as marine mammals. Therefore, coastal or Indigenous populations tend to have elevated exposure ([@c94]). Rice is also a significant contributor to MeHg exposure in certain areas when paddy fields are contaminated by Hg ([@c23]).

Exposure or body burden of Hg is usually estimated by measuring biomarkers. Hg concentrations in tissues, such as hair, urine, blood, and nails, reflect Hg body burden and overall exposure from all sources ([@c6]; [@c30]). Hair Hg concentration is an appropriate and noninvasive biomarker to reflect exposure to MeHg ([@c13]), but not for inorganic ${Hg}^{0}$, as the ${Hg}^{2 +}$ in hair is likely to be demethylated from MeHg demethylation or external deposition ([@c5]). Blood concentration of total Hg is considered as a useful biomarker of exposure to both MeHg and total Hg ([@c13]) as MeHg was found to constitute 70--85% of the total Hg in the blood ([@c31]; [@c51]). There is a strong correlation between hair Hg concentrations and whole blood Hg concentration at an average ratio of 250:1 ([@c3]; [@c13]; [@c44]). Toenail Hg is also used in biomonitoring studies for the general populations to MeHg ([@c6]). Urinary Hg concentration is the most common biomarker for inorganic Hg exposure from occupational sources and from dental amalgams ([@c13]).

High blood pressure (BP) has long been recognized as a leading risk factor for cardiovascular disease. A recent analysis suggests that the burden of high BP has been increasing over the last three decades ([@c25]). Besides the traditional risk factors for hypertension, such as high salt intake and overweight/obesity, environmental exposures to heavy metals may also play an important role ([@c1]; [@c22]; [@c34]; [@c56]). Although the mechanisms of how Hg induces hypertension are not fully understood, plausible explanations include oxidative stress and inflammation, which promote endothelial and renal dysfunction, and binding of selenium-related enzymes ([@c34]). MeHg is generally considered to be the most toxic form and a dose--response relationship has been proposed between MeHg and cardiovascular outcomes ([@c68]). However, hypertension can be induced in experimental animals by acute or chronic administration of both inorganic Hg and MeHg ([@c7]; [@c65]; [@c66]; [@c88]). Although there is extensive literature supporting differing toxic effects and modes of action of inorganic Hg and MeHg on many human organ systems (e.g., [@c55]; [@c13]; etc.), there is no evidence showing a difference in effects on hypertension between inorganic and MeHg. Therefore, this systematic review and meta-analysis will include studies reported for both general and occupational populations exposed to different Hg species. The potential differences will be investigated by sensitivity analysis.

The objectives of this systematic review and meta-analysis were: (1) to evaluate the relationship between mercury exposure and hypertension, systolic BP (SBP), and diastolic BP (DBP), and (2) to explore the heterogeneity in the relationship between mercury exposure and BP outcomes contributed by three main factors: the Hg exposure groups in the studied population; mercury species measured and reported; and the choice of biomarkers. The dose--response relationship between mercury exposure and hypertension and SBP were also explored.

Methods {#s2}
=======

Search Strategy and Study Selection {#s2.1}
-----------------------------------

Three databases, including PubMed (<https://www.ncbi.nlm.nih.gov/pubmed/>), Embase (<https://www.embase.com/home>), and TOXLINE (<https://toxnet.nlm.nih.gov/newtoxnet/toxline.htm/>), were used to find all published epidemiological studies evaluating the association between mercury exposure and hypertension or BP. Free text and Medical Subject Headings (MeSH) terms "mercury" or "methyl mercury" or "Quicksilver" or "dimethylmercury" or "colloidal mercury" AND "hypertension" or "blood pressure" or "cardiovascular disease" or "mortality" or "death" or "myocardial infarction," "stroke" or terms of other cardiovascular outcomes were used. Detailed searching strategy for PubMed can be found in the Supplementary Materials. We adopted a broad searching strategy for health outcomes to increase the sensitivity because hypertension or blood pressure were likely to be reported in studies with other cardiovascular diseases as the main outcome. The search period was January 1966 through February 2017 with no language restrictions ([Figure 1](#f1){ref-type="fig"}). Reference lists of eligible articles were searched for further pertinent articles. Two studies were identified through this search; however, none of them were included in the quantitative synthesis.

![Study selection flow diagram.](EHP2863_f1){#f1}

Two investigators (X.F.H. and K.S.) reviewed each paper. Studies that fulfilled the following *a priori* eligibility criteria were included: (a) original study; (b) cross-sectional, case--control, or a cohort design; and (c) reported Hg exposure and a blood pressure outcome. Our exclusion criteria were: (a) nonoriginal report, an experimental, case report, or a case series, (b) did not include our relationships of interest or no numeric values available ([@c2]; [@c17]; [@c36]), (c) used the same or a population subset of another included study ([@c12]; [@c42]; [@c79]; [@c86]; [@c91]; [@c93]), (d) no adult participants ([@c27]; [@c37]; [@c73]), and (e) the exposed group was not comparable with the control group and no adjustment was made for effect size estimate \[the body weight of the patients and control group differed by $10\,\text{kilograms}$ ([@c59])\]. If more than one paper was published from the same study, the most recent paper or the paper using the best assessment of Hg and/or outcome was included. For studies that reported estimates for more than one biomarker, the estimate for the most appropriate biomarker was preferred. The order of preference was as follows for populations exposed mainly to MeHg: $\text{hair} > \text{blood} > \text{toenail} > \text{urine}$. This order was chosen because the majority of studies measured Hg in hair or blood, and hair Hg most accurately reflects long-term exposure. Urinary Hg was the first choice for studies reporting occupational exposure. We included studies that reported hypertension or BP by Hg exposure categories even if that was not the primary outcome of the study, to ensure all potentially relevant data were considered for meta-analysis.

Data Extraction and Quality Assessment {#s2.2}
--------------------------------------

Two investigators (X.F.H. and K.S.) independently extracted the study data, including study design, study population (location, age, and sex distribution), sample size, Hg exposure matrix and levels, BP and hypertension outcomes, study results (measures of association), and potential confounders accounted for in the statistical analysis. Authors were contacted for information unavailable in the published report ([@c24]). For studies with both continuous and categorical definitions of Hg exposure, we extracted the measures of association by Hg category. For studies with multiple levels of adjustment, we extracted the measure of association obtained from the model adjusted for the most covariates. Any discrepancies were resolved by consensus. X.F.H. and K.S. applied the Newcastle-Ottawa Scale ([@c90]) for case--control and cohort studies to assess quality. The Newcastle-Ottawa Scale includes a series of questions to evaluate the selection of participants into the study, the comparability of groups, and the ascertainment of exposure (for case--control studies) or outcome (for cohort studies), with a maximum score of 9 ([@c90]). Studies scoring $\geq 5$ were categorized as high quality. Cross-sectional studies were evaluated with the Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies ([@c54]). This tool contains 14 questions; however, only those questions that were applicable to cross-sectional studies (7 questions) were selected to evaluate the studies. The overall study rating of poor, fair, or good was based on subjective assessment of the seven questions and agreement among two reviewers. If no adjustments were made for confounding, the cross-sectional study was rated as poor.

Statistical Analysis {#s2.3}
--------------------

For studies that reported hypertension, we extracted or derived odds ratios (ORs), hazard ratios (HRs), and prevalence ratios for hypertension and their standard errors from the published data. For studies with hypertension data but no available measures of association, we estimated the OR and 95% confidence interval (CI) by Hg categories using the number of cases and noncases in the different exposure categories. For studies that reported SBP and DBP levels, we extracted the mean BP levels, corresponding standard errors and sample sizes of the different exposure categories. For studies with missing standard errors for SBP or DBP, an un-weighted average of available standard errors from all included studies was used. For studies that reported OR for hypertension or SBP or DBP change per continuous change of Hg concentration only, OR or SBP or DBP change per interquartile range (IQR) change in Hg concentrations were derived for high vs. low exposure categories.

For summary purposes, we pooled OR estimates for hypertension and weighted mean difference (WMD) comparing the highest and lowest categories of Hg exposure from individual studies using an inverse-variance weighted random-effects model. Studies were categorized into low-to-moderate mercury exposed ($< 2\;\mu g/g$ hair Hg or equivalent) and high mercury exposed ($\geq 2\;\mu g/g$ hair Hg or equivalent) by the mean mercury concentrations in the highest exposed group in those studies. Pooled ORs and WMDs were calculated for all studies and separately for studies conducted in populations exposed to low-to-moderate mercury levels and for studies conducted in populations exposed to high mercury levels. Hereafter in the paper, we use the term "high mercury exposure" to refer to mercury levels above which we observe an increased risk of hypertension. The cut-off of $2\;\mu g/g$ hair Hg was a data-driven value based on the results of this study. Heterogeneity was quantified with the $I^{2}$ statistic ([@c32]). The relative influence of each study on pooled estimates was estimated by omitting one study at a time. Finally, we assessed publication bias using funnel plots (Figure S1 A/B/C).

Subgroup Analysis {#s2.4}
-----------------

Besides Hg exposure level, three additional sets of subgroup analyses were conducted to explore the contribution of the following three factors to the heterogeneity in the relationship between Hg exposure and BP outcomes: (1) exposure group; (2) Hg species; and (3) Hg biomarkers. By exposure group, studies were categorized into three groups including the general population, coastal and Indigenous populations, and occupationally exposed populations. By Hg species, studies were categorized into MeHg, inorganic Hg, and total Hg exposure. Here, Hg species referred to the Hg speciation measured and/or reported in the study, but not necessarily the main form of Hg the study population was exposed to. It can be assumed that both the general populations, and coastal and Indigenous populations were exposed mainly to MeHg, and occupational exposure was mainly inorganic Hg. By Hg biomarkers, a pairwise comparison was shown for results obtained with two different biomarkers within each study, i.e., hair vs. blood, blood vs. urinary, and hair vs. urinary.

Dose-Response Analysis {#s2.5}
----------------------

For studies that reported hypertension or SBP or DBP results for three or more Hg categories, dose-response meta-analysis was performed. For hypertension, we first plotted the ORs by exposure category from each study ([@c1]; [@c45]). Dose-response meta-analyses were then conducted. Besides linear regression ([@c28]), a restricted cubic splines regression was also fitted, with knots fixed at percentiles 15%, 50%, and 85% through the distribution ([@c60]). For SBP and DBP, we performed dose-response meta-analysis of differences in means ([@c14]). Harmonized hair Hg equivalent values were assigned to Hg exposure categories of studies eligible for dose-response meta-analysis that reported Hg exposure in another matrix (i.e., blood, toenail, urine). We adopted a conversion ratio of 250 between Hg concentrations in hair (in $\mu g/g$) and in the blood (in $\mu g/L$) ([@c13]). Hg concentrations in toenail (in $\mu g/g$) and in urine ($\mu g/L$) were converted to hair-Hg (in $\mu g/g$) using a regression model developed by Ohno et al. ([@c58]). All statistical analyses were performed using Stata software, version 14.0 (StataCorp, College Station, TX, USA), except for the dose-response meta-analysis of differences in means for SBP, which was conducted using RStudio 1.0.136 (RStudio, Inc.). For reporting, we followed the Meta-analysis of Observational Studies in Epidemiology ([@c75]) and the Preferred Reporting Items for Systematic Review and Meta-Analysis ([@c49]) guidelines.

Results {#s3}
=======

Study Characteristics {#s3.1}
---------------------

This systematic review covers more than 55,000 participants from 17 countries, including occupational exposures and populations exposed to Hg through diets rich in fish ([Table 1](#t1){ref-type="table"}). Thirty studies, published between 1990 and 2017 were identified. One is cohort study ([@c53]), one is case-control study ([@c71]), and all the rest are cross-sectional design. Three studies have certain exposure history data ([@c11]; [@c38]; [@c92]). One case-control study ([@c29]) and three cohort studies ([@c15]; [@c85], [@c84]) were considered as cross-sectional as we only used data from controls or the baseline data. Eleven studies were conducted at low to moderate mercury exposure levels (mean Hg concentration of the highest exposure group $\leq 2\;\mu g/g$ in hair or equivalent), nine of which were conducted in the United States ([@c4]; [@c26]; [@c50]; [@c53]; [@c63]; [@c71]; [@c72]; [@c87]; [@c89]), the rests were from Canada ([@c80]) and Europe ([@c29]). Eighteen studies were conducted at high mercury exposure levels (mean Hg concentration of the highest exposure group $> 2\;\mu g/g$ in hair or equivalent) ([@c15]; [@c20]; [@c24]; [@c33]; [@c35]; [@c38]; [@c41]; [@c57]; [@c62]; [@c61]; [@c64]; [@c67]; [@c82], [@c83], [@c81], [@c85], [@c84]; [@c92]).

###### 

Characteristics of studies included in the systematic review and meta-analysis.

Table 1 lists reference citations in the first column; the corresponding population, exposure group, mean age or age range (years), male (percentage), number, biomarker (units), form, mercury concentration, outcome, matrix available, definition of HPT, blood pressure measurement, and variables adjusted for are listed in the other columns.

  Reference   Population                                     Exposure group             Mean age or age range (years)  Male (%)   N       Biomarker (unit)      Form                                         Mercury concentration                                                               Outcome   Matrix available   Definition of HPT                                   Blood pressure measurement                                                                                                                           Variables adjusted for
  ----------- ------------------------------------ ----------------------------------- ------------------------------- ---------- ------- --------------------- -------------------------------------------- ----------------------------------------------------------------------------------- --------- ------------------ --------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@c4]       Wisconsin, USA                               General population                       59.4               52.5       101     Hair ($\mu g/g$)      Total                                        Mean 0.27 (95% CI: 0.23, 0.32)                                                      HPT, BP   H, B               $140/90\,\text{mmHg},$ BP medication                Average of 2 measurements in 5 minutes interval using standard mercury sphygmomanometer, after seated for 15 minutes                                 Age, gender, BMI, fish intake, hypertension
  [@c11]      Whaling men, Faroe Islands            Coastal and Indigenous population               54.8               100        42      Blood ($\mu g/L$)     Methyl                                       GM 29.5 (range: 5.19, 128.4)                                                        BP        H, B, T            NA                                                  Measured with standard mercury sphygmomanometers in seated position                                                                                  Age, smoking, alcohol consumption, fish consumption, BMI
  [@c15]      Finland                                      General population                      42--60              100        1828    Hair ($\mu g/g$)      Total[^*a*^](#t1n1){ref-type="table-fn"}     Mean 1.90 (SD: 1.95)                                                                BP        H                  NA                                                  Average of six measurements with zero mercury sphygmomanometer (after a supine rest of 5min, 3 in supine, 1 in standing and 2 in sitting position)   None
  [@c20]      South Korea                                  General population                       45.5               43.5       2114    Blood ($\mu g/L$)     Total                                        GM 3.90 (geometric SD: 1.88)                                                        HPT, BP   B                  $130/85\,\text{mmHg}$, BP medication                Measured according to protocol                                                                                                                       Age, gender, smoking, alcohol, residence area, seafood intake ($+ \text{income}\,\text{for}\,\text{HTN}$)
  [@c24]      Amazon, Brazil                        Coastal and Indigenous population               35.2               53         251     Hair ($\mu g/g$)      Total                                        Mean 17.8 (range: 0.21, 77.2)                                                       HPT       H                  SBP $\geq 130\,\text{mmHg}$                         Measured with standard mercury sphygmomanometers in sitting position                                                                                 Age, gender, BMI, smoking, community
  [@c26]      Dentist, Michigan, USA                     Occupational population                    52.3               38         262     Hair ($\mu g/g$)      Total                                        Median 0.28 (IQR: 0.14, 0.55)                                                       BP        H, U               NA                                                  Measured in sitting position with device (Omron HEM 432-C)                                                                                           Age, gender, BMI, BP medication
  [@c29]      European & Israel                            General population                       53.2               100        724     Toenail ($\mu g/g$)   Tota*l*[^*a*^](#t1n1){ref-type="table-fn"}   Mean 0.25 (IQR: 0.15, 0.40)                                                         HPT       T                  Self-report                                         NA                                                                                                                                                   None, age balanced across quintiles
  [@c33]      Smokers, South Korea                         General population                      16--75              62.7       236     Hair ($\mu g/g$)      Total                                        Mean 1.41 (SD: 1.1)                                                                 BP        H                  NA                                                  Measured after 10 min of rest in a sitting position using a model TM-2655P automatic sphygmomanometer                                                Age
  [@c35]      Inuit, Canada                         Coastal and Indigenous population              18--78              38.7       2169    Blood ($\mu g/L$)     Total                                        Median 7.8 (range: 0.3, 70)                                                         HPT, BP   B                  $140/90\,\text{mmHg}$, BP medication, self-report   Average of 3 readings from a BpTRU™ Vital Signs Monitor                                                                                              Age, sex, smoking status, systolic blood pressure, TC/HDL, BMI, physical inactivity, diabetes, marital status, education, income, red bloodcellomega-3 and omega-6 fatty acids, log transformed blood concentration of lead, cadmium, sum of PCBs and sum of PBDEs
  [@c38]      Mercury miners, Slovenia                   Occupational population                     45                100        120     Urine ($\mu g/L$)     Total                                        Mean 69.3 (range: 26, 158)                                                          HPT, BP   B, U               $140/90\,\text{mmHg}$                               No detail                                                                                                                                            None
  [@c41]      South Korea                                  General population                     $\geq 20$            100        3783    Blood ($\mu g/L$)     Total\*                                      Mean 4.96 (SE: 0.07)                                                                HPT       B                  $130/85\,\text{mmHg}$, BP medication                Average of 3 readings using a mercury sphygmomanometer in seated position                                                                            Age, BMI, residence area, education level, smoking, drinking status, exercise, AST, ALT, lead, cadmium
  [@c50]      Elderly, Boston, USA                         General population                        72                100        639     Toenail ($\mu g/g$)   Total[^*a*^](#t1n1){ref-type="table-fn"}     Median 0.22 (IQR: 0.07, 0.38)                                                       HPT, BP   T                  $140/90\,\text{mmHg}$, BP medication                Average of both arms with standard mercury sphygmomanometers                                                                                         Age, smoking, pack-years smoking, season of clinical visit, year of clinical visit, BMI, education, race/ethnicity, alcohol intake, fish intake
  [@c53]      Health professionals & Nurses, USA           General population                   M 60.2 F 53.1          26.9       6045    Toenail ($\mu g/g$)   Total                                        Men Median 0.30 (90% CI: 0.07, 1.31) Women Median 0.21 (90% CI: 0.07, 0.76)         HPT, BP   T                  Self-report                                         Self-reported usual blood pressure in $10\,\text{mmHg}$ categories                                                                                   Age, gender, race, month of toenail return, family history of hypertension, smoking status, BMI, diabetes, hypercholesterolemia, future cardiovascular disease status, physical activity, alcohol use, fish consumption, and consumption of whole grains, unprocessed meats, processed meats, fruits, and vegetables
  [@c57]      Inuit, Greenland                      Coastal and Indigenous population               46.9               43.6       1861    Blood ($\mu g/L$)     Methyl                                       Men Median 22 (IQR: 11, 41) Women Median 16 (IQR: 8.8, 34.1)                        HPT       B                  $140/90\,\text{mmHg}$, BP medication                Average of the second and third reading using automatic BP apparatus (Kivex UA 779), after 5 minutes rest                                            Age, smoking, selenium, n-3/n-6 fatty acids, waist circumference
  [@c63]      USA                                          General population                       46.6               48.6       6607    Blood ($\mu g/L$)     Total                                        GM 1.03 (95% CI: 0.95, 1.11)                                                        HPT, BP   B, U               $140/90\,\text{mmHg}$, BP medication, self-report   Average of up to 3 measurements in 5 minutes interval using standard mercury sphygmomanometer, disregarding the first measurement                    Age, gender, race/ethnicity, education, BMI, alcohol, cotinine, omega-3, total caloric intake, BP medication
  [@c62]      South Korea                                  General population                     $\geq 20$            49.6       8371    Blood ($\mu g/L$)     Total[^*a*^](#t1n1){ref-type="table-fn"}     GM 3.90 (geometric SD: 1.80)                                                        BP        B                  NA                                                  Average of second and third time measurements in 5 minutes interval using standard mercury sphygmomanometer                                          Age, gender, smoking status, alcohol consumption, job status, education, residence, diabetes mellitus
  [@c64]      Greenland & Denmark                   Coastal and Indigenous population              20--60              43         186     Blood ($\mu g/L$)     Total[^*a*^](#t1n1){ref-type="table-fn"}     Greenlanders Median 16.2 (range: 0.8, 117.7) Danes Median 2.2 (range: 0.8, 117.7)   BP        B                  NA                                                  Twenty-four hour ambulatory BP measurement (every 15 mins during daytime, every 30 mins during night-time)                                           Age, gender, BMI, residence
  [@c67]      Gold miners, Ghana                         Occupational population                    30.6               60         70      Urine ($\mu g/L$)     Total                                        Median 4.24 (IQR: 1.24, 11.0)                                                       BP        H, U               NA                                                  Average of 3 readings using a mercury sphygmomanometer in seated position                                                                            Age, gender, smoking status
  [@c71]      USA                                          General population                       31.2               49.6       10537   Urine ($\mu g/L$)     Total[^*a*^](#t1n1){ref-type="table-fn"}     Normal BP group Mean 0.68 (SD: 1.04) High BP group Mean 0.54 (SD: 0.75)             HPT       U                  $140/90\,\text{mmHg}$                               NA                                                                                                                                                   Age, gender, ethnicity, BMI, urine creatinine
  [@c72]      Dental amalgam, Colorado USA               Occupational population                     23                40.6       101     Urine ($\mu g/L$)     Total                                        Non-amalgam Mean 1.23 (SD: 1.79) Amalgam Mean 3.70 (SD: 3.78)                       BP        H, U                                                                   Several readings in sitting position by the auscultator method, mostly during evening time                                                           None
  [@c82]      Inuit, Nunavik, Canada                Coastal and Indigenous population               34.3               43.6       732     Blood ($\mu g/L$)     Total[^*a*^](#t1n1){ref-type="table-fn"}     Mean 50.2 (95% CI: 46.6, 54.1)                                                      BP        B                  NA                                                  Average of the second and third reading using mercury sphygmomanometers, after 5 minutes rest                                                        Age, $\text{age}^{2}$, gender, EPA, selenium, alcohol consumption, waist circumference
  [@c80]      The Cree, Quebec, Canada              Coastal and Indigenous population                35                53.2       791     Hair ($\mu g/g$)      Total[^*a*^](#t1n1){ref-type="table-fn"}     Median 0.53 (IQR: 0.15, 1.62)                                                       BP        H, B               NA                                                  Average of the second and third reading using mercury sphygmomanometers, after 5 minutes rest                                                        Age, sex, HDL-cholesterol, LDL-cholesterol, waist circumference, total n-3 PUFAs, triglycerides, fasting glucose, selenium, lead, PCB 153 and smoking.
  [@c83]      French Polynesia                      Coastal and Indigenous population               48.6               47.2       180     Blood ($\mu g/L$)     Total[^*a*^](#t1n1){ref-type="table-fn"}     Median 13.5 (IQR: 8.5, 22)                                                          BP        B                  NA                                                  Average of the second and third reading using mercury sphygmomanometers, after 5 minutes rest                                                        Age, sex, waist circumference, fasting glucose, triglycerides, anti-hypertensive treatment, selenium, total n-3 PUFA
  [@c81]      Inuit, Quebec, Canada                 Coastal and Indigenous population                38                42.2       313     Blood ($\mu g/L$)     Methyl                                       Median 17.0 (IQR: 9.0, 28.4)                                                        BP        B                  NA                                                  Average of the second and third reading using mercury sphygmomanometers, after 5 minutes rest                                                        Age, sex, waist circumference, $\text{DHA} + \text{EPA}$, and total PCBs
  [@c84]      Finland                                      General population                       52.8               100        1857    Hair ($\mu g/g$)      Methyl[^*a*^](#t1n1){ref-type="table-fn"}    Mean 1.91 (range: 0, 15.67)                                                         HPT       H                  No detail                                           NA                                                                                                                                                   None
  [@c85]      Finland                                      General population                      53--73              51.6       768     Hair ($\mu g/g$)      Methyl                                       Mean 1.42 (SD: 1.54)                                                                BP        H                  NA                                                  Average of six measurements with zero mercury sphygmomanometer (after a supine rest of 5min, 3 in supine, 1 in standing and 2 in sitting position)   Age, gender, examination year, hypertension in family, smoking, leisure-time physical activity, alcohol consumption, BMI, education, employment status, 24-h urinary potassium and sodium excretion
  [@c87]      USA                                          General population                       32.9               0          1240    Blood ($\mu g/L$)     Total                                        Mean 1.8 (range: 0.1, 21.4)                                                         BP        B                  NA                                                  Average of up to 3 measurements in 5 minutes interval using standard mercury sphygmomanometer                                                        Age, race, income, body mass index, pregnancy status, and dietary sodium, potassium, and total calories
  [@c89]      Pregnant women, Baltimore, USA               General population                    16.4--36.7            0          263     Blood ($\mu g/L$)     Methyl                                       GM 0.95 (95% CI: 0.87, 1.07)                                                        BP        B                  NA                                                  Continuous blood pressure measurements were collected with a General Electric Corometrics model 120 series fetal monitor                             Age, race/ethnicity, median neighborhood household income, pregnancy, body mass index, smoking during pregnancy, $\text{EPA} + \text{DHA}$ and selenium.
  [@c92]      Minamata, Japan                       Coastal and Indigenous population             $\geq 10$            41.7       120     Hair ($\mu g/g$)      Methyl                                       Low exposure $< 6.2$ High exposure $> 28.3$                                         HPT, BP   H                  $160/95\,\text{mmHg}$                               Measured using a mercury sphygmomanometer by doctors in lying position                                                                               Age, occupation, past history of alcoholism, and past history of diabetes

Note: BMI, body mass index; BP, blood pressure measurement; HPT, hypertension; GM, geometric mean; IQR, inter-quartile range; SD, standard deviation; SE, standard error; H, hair; B, blood; S, serum; U, urine; T, toenail; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; PUFAs, polyunsaturated fatty acids; HDL, high density lipoprotein; TC/HDL, ratio of total cholesterol to high density lipoprotein. NA, outcome was not reported in the study.

Assumed from study.

The studies could be broadly categorized into 3 exposure groups: general population, coastal and Indigenous population, and occupationally exposed population. Within the general population group, US population are generally exposed to low level of Hg. In comparison, the South Korean ([@c20]; [@c33]; [@c41]; [@c62]) and Finnish populations ([@c15]; [@c85], [@c84]) were exposed to moderate to high level of Hg. The coastal and Indigenous population consists of Inuit living in the Arctic ([@c35]; [@c57]; [@c64]; [@c82], [@c81]), people living in Faroe Islands and French Polynesia ([@c11]; [@c83]), Brazilian Amazon ([@c24]), and Minamata area in Japan ([@c92]). For occupational exposures, two studies reported exposure related to dental amalgam ([@c26]; [@c72]) and another two studies reported exposure from mining ([@c38]; [@c67]). For comparison of Hg species reported, a total of seven studies measured MeHg ([@c11]; [@c57]; [@c81]; [@c84], [@c85]; [@c89]; [@c92]) and the other twenty-three studies reported total Hg. Only eight studies reported concentrations of multiple Hg biomarkers in the studied populations within each study, of which three reported Hg in hair and urine ([@c26]; [@c67]; [@c72]), three reported Hg in hair and blood ([@c4]; [@c11]; [@c80]), and another two reported in blood and urine ([@c38]; [@c63]).

Quality Assessment {#s3.2}
------------------

Most of the United States and South Korean studies were based on national population bio-monitoring studies like NHANES ([@c9]) and KNHANES ([@c39]). Three reports from Finland were all from the Kuopio Ischemic Heart Disease Risk Factor Study ([@c69]). Most of the Inuit studies were also based on locally representative bio-monitoring studies ([@c16]; [@c70]). All the studies used Hg biomarkers at the individual level to characterize Hg exposure ([Table 1](#t1){ref-type="table"}). Of the fourteen studies that reported hypertension, four studies defined the outcome based on measured BP only ([@c24]; [@c38]; [@c71]; [@c92]), two studies defined the outcome based on self-report only ([@c29]; [@c53]), one study did not report the definition ([@c84]), and the rests defined the outcome based on measured BP plus either self-report or taking BP medication ([@c4]; [@c20]; [@c35]; [@c41]; [@c50]; [@c57]; [@c63]). Of the 23 studies that reported SBP or DBP, most were based on the average of more than two measurements in the sitting position; two studies did not provide any measurement details ([@c20]; [@c38]). Five of the 29 studies did not adjust for potential confounders ([@c15]; [@c29]; [@c38]; [@c72]; [@c85]), one only adjusted for age ([@c33]), and the rest adjusted for multiple confounders. The quality assessments for the included cross-sectional studies are provided in [Table 2](#t2){ref-type="table"}. The Newcastle-Ottawa scale score was 7 for the included cohort study ([@c53]) and 8 for the case-control study ([@c71]).

###### 

Quality assessment of cross-sectional studies included in the systematic review and meta-analysis.

Table 2 lists reference citations in the first column. The corresponding information on whether Questions 1, 2, 3, 4, 5, 6, and 7 of the Quality Assessment Tool for Cross-Sectional Studies are included in those studies is listed in the other columns. The overall ratings are presented in the last column.

  Study    Questions of the Quality Assessment Tool for Cross-Sectional Studies[^*a*^](#t2n1){ref-type="table-fn"}   Overall rating                                     
  -------- --------------------------------------------------------------------------------------------------------- ---------------- ----- ----- --------- ----- ----- ------
  [@c4]    Yes                                                                                                       Yes              Yes   Yes   Yes       No    Yes    Fair
  [@c11]   Yes                                                                                                       Yes              Yes   Yes   Yes       Yes   Yes    Good
  [@c15]   Yes                                                                                                       Yes              Yes   Yes   Unclear   No    No     Poor
  [@c20]   Yes                                                                                                       Yes              Yes   Yes   Yes       No    Yes    Good
  [@c24]   No                                                                                                        Yes              Yes   Yes   Yes       Yes   Yes    Good
  [@c26]   Yes                                                                                                       Yes              Yes   Yes   Yes       No    Yes    Good
  [@c29]   Yes                                                                                                       No               Yes   Yes   No        No    Yes    Fair
  [@c33]   No                                                                                                        Yes              Yes   Yes   Yes       No    No     Poor
  [@c35]   Yes                                                                                                       Yes              Yes   Yes   Yes       No    Yes    Good
  [@c41]   Yes                                                                                                       Yes              Yes   Yes   Yes       No    Yes    Fair
  [@c50]   Yes                                                                                                       Yes              Yes   Yes   Yes       No    Yes    Good
  [@c57]   Yes                                                                                                       Yes              Yes   Yes   Yes       No    Yes    Good
  [@c63]   Yes                                                                                                       Yes              Yes   Yes   Yes       No    Yes    Good
  [@c62]   Yes                                                                                                       Yes              Yes   Yes   Yes       No    Yes    Good
  [@c64]   Yes                                                                                                       Yes              Yes   Yes   Yes       No    Yes    Good
  [@c67]   Unclear                                                                                                   Yes              Yes   Yes   Yes       No    No     Fair
  [@c72]   Yes                                                                                                       No               Yes   Yes   Yes       No    No     Poor
  [@c82]   Yes                                                                                                       Yes              Yes   Yes   Yes       No    Yes    Good
  [@c80]   No                                                                                                        Yes              Yes   Yes   Yes       No    Yes    Fair
  [@c83]   No                                                                                                        No               Yes   Yes   Yes       No    Yes    Fair
  [@c81]   No                                                                                                        Yes              Yes   Yes   Yes       No    No     Fair
  [@c84]   Yes                                                                                                       Yes              Yes   Yes   Unclear   No    No     Poor
  [@c85]   No                                                                                                        Yes              Yes   Yes   Yes       No    Yes    Fair
  [@c87]   Yes                                                                                                       Yes              Yes   Yes   Yes       No    Yes    Good
  [@c89]   Yes                                                                                                       Yes              Yes   Yes   No        Yes   No     Fair
  [@c93]   Yes                                                                                                       Yes              Yes   Yes   Unclear   Yes   No     Poor

The numbers correspond to the following questions to assess study quality. The overall study rating of poor, fair, or good was based on subjective assessment of the seven questions and agreement among two reviewers. If no adjustments were made for confounding, the cross-sectional study was rated as poor.

1 "Was the participation rate of eligible persons at least 50%?"

2 "Were all subjects selected or recruited from the same or similar populations?"

3 "Did the study examine different levels of the exposure as related to the outcome?"

4 "Were the exposure measures clearly defined, valid, reliable, and implemented consistently across the study participants?"

5 "Were the outcome measures clearly defined, valid, reliable, and implemented consistently across all study participants?"

6 "Were the outcome assessors blinded to the exposure status of participants?"

7 "Were the key potential confounding variables measured and adjusted statistically?"

ORs for Hypertension {#s3.3}
--------------------

A total of fourteen studies evaluated the association between Hg exposure and hypertension, with one study reporting estimates separately for men and women ([@c57]) ([Figure 2](#f2){ref-type="fig"}). Nine of the fifteen studies reported a positive association ([@c4]; [@c20]; [@c24]; [@c29]; [@c35]; [@c38]; [@c71]; [@c84]; [@c92]). Of the six studies conducted at low to moderate mercury exposure level, five were conducted in the United States ([@c4]; [@c53]; [@c63]; [@c71]; [@c72]), and one included participants from Europe and Israel ([@c29]). There was only one cohort study included in the review and that study reported a negative association comparing the highest with the lowest exposure group with an OR 0.82 (95% CI: 0.62,1.08) ([@c53]). Guallar et al. ([@c29]) reported a positive association with an OR 1.81 (95% CI: 1.02, 3.21) based on 724 participants from eight European countries and Israel. Nine studies evaluated the association between Hg exposure and hypertension at high exposure level. Only two studies in the high exposure category showed negative associations ([@c41]; [@c57]). Nielsen et al. ([@c57]) identified a positive association in females, where as a negative association in males. Studies were sorted in ascending order according to the converted hair Hg concentration in the highest exposure categories.

![ORs of hypertension by mercury exposure levels. The area of each square is proportional to the inverse of the variance of the estimated log OR. Black diamonds represent point estimates of OR and horizontal lines represent 95% confidence intervals (CIs). The open diamonds represent the combined OR for each subgroup and the overall OR for all studies. The solid line represents $\text{OR} = 1$. The dash line represents the point estimate of overall OR for all studies. The "metan" package in Stata only outputs *p* value up to 3-digit numbers for the heterogeneity tests. We reported in the text "$p < 0.0001$" when the figures showed "$p = 0.000$". Note: CI, confidence interval; HPT, hypertension; OR, odds ratio. \* indicates mercury form was not described in the Methods section and was assumed by authors of the present review.](EHP2863_f2){#f2}

The pooled OR ([Figure 2](#f2){ref-type="fig"}) for the six studies conducted at low to moderate mercury exposure level was 1.12 (95% CI: 0.82, 1.52; *p* value for $\text{heterogeneity} = 0.006$; $I^{2} = 69.2\%$), with the study by Bautista et al. ([@c4]) as moderately influential. The OR estimate excluding this study was 1.02 (95% CI: 0.78, 1.34; *p* value for $\text{heterogeneity} = 0.029$; $I^{2} = 62.9\%$). The corresponding pooled OR for the nine studies conducted at high mercury exposure level was 1.35 (95% CI: 0.99, 1.83; *p* value for $\text{heterogeneity} = 0.003$; $I^{2} = 65.2\%$). The overall pooled OR for hypertension was 1.24 (95% CI: 1.00, 1.52; *p* value for $\text{heterogeneity} < 0.0001$; $I^{2} = 66.2\%$).

SBP and DBP {#s3.4}
-----------

Twenty-three studies (10 at low-to-moderate mercury-exposure level, 13 at high mercury-exposure level) investigated the association between Hg exposure and SBP or DBP (Figure S2, S3). The pooled mean difference in SBP between the highest and lowest Hg exposure categories for studies conducted at low-to-moderate exposure levels, and at high exposure levels, and for all studies were $- 0.18\,\text{mmHg}$ (95% CI: $- 1.49$, 1.13; *p*-value for $\text{heterogeneity} < 0.0001$; $I^{2} = 74.8\%$), $2.20\,\text{mmHg}$ (95% CI: 0.90, 3.49; *p*-value for $\text{heterogeneity} = 0.002$; $I^{2} = 60.6\%$), and $1.32\,\text{mmHg}$ (95% CI: 0.03, 2.60; *p*-value for $\text{heterogeneity} < 0.0001$; $I^{2} = 86.5\%$), respectively (Figure S2). The corresponding mean difference estimates for DBP were $0.58\,\text{mmHg}$ (95% CI: $- 0.39$, 1.56; *p*-value for $\text{heterogeneity} < 0.0001$; $I^{2} = 82.5\%$), $1.24\,\text{mmHg}$ (95% CI: $- 0.02$, 2.51; *p*-value for $\text{heterogeneity} < 0.0001$; $I^{2} = 80.8\%$), and $0.96\,\text{mmHg}$ (95% CI: 0.08, 1.85; *p*-value for $\text{heterogeneity} < 0.0001$; $I^{2} = 87.6\%$), respectively (Figure S3).

Subgroup Analysis {#s3.5}
-----------------

The heterogeneity in the relationship between Hg exposure and BP outcomes by exposure group, and by Hg species were explored by population subgroups. The pooled OR for hypertension in general population, coastal and Indigenous population, and occupational exposed population were 1.08 (95% CI: 0.89, 1.32), 1.48 (95% CI: 0.81, 2.73), and 2.08 (95% CI: 1.28, 3.38) respectively ([Figure 3](#f3){ref-type="fig"}). Similar to hypertension, the pooled mean differences in SBP and DBP were larger for the occupationally exposed population \[$3.91\,\text{mmHg}$ (95% CI: 0.41, 7.42) in SBP and $2.70\,\text{mmHg}$ (95% CI: $- 0.33$, 5.74) in DBP\], followed by the coastal and Indigenous population and then the general population \[$1.36\,\text{mmHg}$ (95% CI: $- 1.11$, 3.84) in SBP and $0.41\,\text{mmHg}$ (95% CI: $- 1.58$, 2.40) in DBP\] (Figure S4, S5). Within each population subgroup, there was a general trend towards larger differences in SBP and DBP with elevated Hg exposure levels. No differences in SBP or DBP were observed in studies that measured MeHg; marginal differences were observed in studies measured total Hg \[($1.19\,\text{mmHg}$ (95% CI: $- 0.34$, 2.71) in SBP and $1.01\,\text{mmHg}$ (95% CI: $- 0.12$, 2.14) in DBP\], and significant differences were observed in studies measured inorganic Hg (mainly in inorganic form) \[$5.08\,\text{mmHg}$ (95% CI: 1.01, 9.14) in SBP and $3.42\,\text{mmHg}$ (95% CI: $- 0.79$, 7.63) in DBP\] (Figure S6, S7). The impact of the choice of biomarkers on the relation between Hg exposure and blood pressure outcomes was also investigated (Figure S8, S9). Within each study, the direction and the effect size were similar between Hg biomarkers, except for one study ([@c38]). In this study, the blood MeHg concentration (which is not a good biomarker for inorganic exposure from mining) is higher in the control group than among the miners. In contrast, the miners had higher urine total Hg concentrations than subjects in the control group had.

![Odds ratios (ORs) of hypertension by mercury exposure groups. The area of each square is proportional to the inverse of the variance of the estimated log OR. Black diamonds represent point estimates of OR and horizontal lines represent 95% CIs. The open diamonds represent the combined OR for each subgroup. The solid line represents $\text{OR} = 1$. Note: CI, confidence interval; HPT, hypertension; OR, odds ratio.](EHP2863_f3){#f3}

Dose--response Analysis for Hypertension {#s3.6}
----------------------------------------

Eleven entries from nine studies reported more than three Hg exposure categories ([Table 3](#t3){ref-type="table"}), two of which reported men and women separately ([@c43]; [@c57]). A nonlinear dose--response curve was fitted from the dose--response meta-analysis ([Figure 4](#f4){ref-type="fig"}). The OR of hypertension decreased with hair Hg concentration until $3\;\mu g/g$, then began to increase steadily. The slope of the curve after the hair Hg concentration of $6\;\mu g/g$ might not be as accurate because there are only 9 data points (20%) available ([Table 3](#t3){ref-type="table"}). Of the nine studies, six showed a positive dose--response relationship ([@c20]; [@c24]; [@c29]; [@c35]; [@c84]; [@c92]), two studies conducted in the United States showed a negative relationship ([@c53]; [@c63]), and one study showed opposite trend for male and female ([@c57]) (Figure S10). The dose--response relationship between mercury exposure and SBP was also explored. The trend was similar to that of hypertension, the mean difference in systolic blood pressure decreased first and then started to increase at hair Hg concentration $2–3\;\mu g/g$. However, this figure needs to be interpreted with caution because the estimates for CIs were not reliable due to lack of data (Figure S11).

![Dose--response relationship between mercury exposure and odds ratio of hypertension ($p\,\text{for}\,\text{nonlinearity} = 0.32$). Data were modeled with fixed-effects restricted cubic spline models with 3 knots (at 15^th^, 50^th^, and 85^th^ percentile) using the Greenland and Longnecker method to estimate the covariances of multivariable-adjusted odds ratios. Lines with long dashes represent the pointwise 95% confidence intervals for the fitted nonlinear trend (solid line). Short dash line represents the linear trend.](EHP2863_f4){#f4}

###### 

Studies eligible for dose--response analysis.

Table 3 lists reference citations in the first column; the corresponding original biomarker, exposure category, assigned hair mercury concentration (micrograms per gram), cases, number, and odds ratio (95 percent confidence interval) are listed in the other columns.

  Reference                                   Original biomarker        Exposure category  Assigned hair mercury concentration ($\mu g/g$)[^*a*^](#t3n1){ref-type="table-fn"}   cases   N                    OR (95% CI)
  ------------------------------------------- ------------------------ ------------------- ------------------------------------------------------------------------------------ ------- ------ ---------------------------------------
  [@c20]                                      Blood Hg ($\mu g/L$)          $< 2.99$       0                                                                                    199     705     --[^*b*^](#t3n2){ref-type="table-fn"}
                                                                           2.99--4.88      1.1                                                                                  258     705               1.12 (0.86, 1.46)
                                                                           $\geq 4.88$     2.74                                                                                 335     705               1.28 (0.97, 1.69)
  [@c24][^*c*^](#t3n3){ref-type="table-fn"}   Hair Hg ($\mu g/g$)              5.6         0                                                                                    11      80                       --
                                                                              15.4         15.4                                                                                 17      87                2.11 (0.84, 5.36)
                                                                              31.0         31.0                                                                                 28      92                3.80 (1.50, 9.50)
  [@c29]                                      Toenail Hg ($\mu g/g$)          0.11         0                                                                                    15      145                      --
                                                                              0.17         0.49                                                                                 19      145               1.27 (0.62, 2.59)
                                                                              0.24         0.66                                                                                 17      145               1.13 (0.55, 2.36)
                                                                              0.36         0.96                                                                                 21      145               1.40 (0.69, 2.82)
                                                                              0.66         1.69                                                                                 25      145               1.66 (0.84, 3.29)
  [@c53] M                                    Toenail Hg ($\mu g/g$)          0.08         0                                                                                    144     324                      --
                                                                              0.18         0.52                                                                                 152     325               1.02 (0.81, 1.30)
                                                                              0.30         0.81                                                                                 155     325               1.03 (0.81, 1.32)
                                                                              0.46         1.2                                                                                  149     325               0.97 (0.75, 1.25)
                                                                              1.00         2.52                                                                                 138     325               0.82 (0.62, 1.08)
  [@c53] F                                    Toenail Hg ($\mu g/g$)          0.08         0                                                                                    578     884                      --
                                                                              0.15         0.44                                                                                 558     884               0.99 (0.88, 1.12)
                                                                              0.21         0.59                                                                                 561     884               1.01 (0.90, 1.14)
                                                                              0.31         0.83                                                                                 553     884               1.01 (0.89, 1.14)
                                                                              0.64         1.64                                                                                 552     884               0.96 (0.84, 1.09)
  [@c57] M                                    Blood Hg ($\mu g/L$)            4.78         0                                                                                    82      161                      --
                                                                              12.75        3.57                                                                                 85      173               1.04 (0.62, 1.73)
                                                                              21.65        6.06                                                                                 53      151               0.65 (0.37, 1.15)
                                                                              35.43        9.92                                                                                 69      159               0.84 (0.45, 1.57)
                                                                              81.07        22.7                                                                                 43      161               0.53 (0.26, 1.10)
  [@c57] F                                    Blood Hg ($\mu g/L$)            3.33         0                                                                                    51      209                      --
                                                                              9.20         2.58                                                                                 66      213               1.29 (0.77, 2.18)
                                                                              15.81        4.43                                                                                 56      204               1.09 (0.63, 1.89)
                                                                              26.54        7.43                                                                                 78      206               1.51 (0.85, 2.69)
                                                                              54.63        15.3                                                                                 71      208               1.39 (0.72, 2.70)
  [@c63]                                      Blood Hg ($\mu g/L$)         0.10--0.49      0                                                                                    168     611                      --
                                                                           0.50--0.95      0.2                                                                                  212     612               1.13 (0.95, 1.33)
                                                                           0.96--1.83      0.39                                                                                 212     612               0.98 (0.75, 1.27)
                                                                           1.84--32.8      0.52                                                                                 195     612               0.83 (0.63, 1.09)
  [@c84]                                      Hair Hg ($\mu g/g$)           $< 0.84$       0                                                                                    249     624                      --
                                                                           0.84--1.99      1.42                                                                                 256     625               1.03 (0.84, 1.26)
                                                                           $\geq 2.00$     4.06                                                                                 272     622               1.09 (0.89, 1.34)
  [@c92]                                      Hair Hg ($\mu g/g$)              2.1         0                                                                                    160     755                      --
                                                                              21.5         21.5                                                                                 217     1450              0.60 (0.50, 0.80)
                                                                              30.0         30                                                                                   215     833               1.60 (1.20, 2.10)
  [@c35]                                      Blood Hg ($\mu g/L$)             2.4         0                                                                                    183     916                      --
                                                                               5.2         1.46                                                                                 26      166               0.48 (0.26, 0.88)
                                                                              12.2         3.42                                                                                 57      168               1.58 (0.96, 2.60)
                                                                              19.6         5.45                                                                                 266     919               1.04 (0.71, 1.52)

Note: Studies reporting at least three mercury exposure categories were eligible for dose--response meta-analysis.

Mercury (Hg) concentrations in blood (in $\mu g/L$) were converted to Hg concentration in hair (in $\mu g/g$) with a ratio of 280 based on our own unpublished meta-analysis. Hg concentrations in toenail (in $\mu g/g$) were converted to hair mercury (in $\mu g/g$) using regression model developed by Ohno et al. ([@c58]). No conversion factor available between serum Hg and hair-Hg.

Reference group.

From personal communication from M. Fillion.

Discussion {#s4}
==========

The association of Hg exposure and hypertension has been controversial. Differences in study populations and exposure levels, different exposure groups, different Hg species, different Hg biomarkers used to assess the exposure, and confounding effects (e.g., fish consumption), all contribute to the discrepancies observed in the published studies. To our knowledge, this review is the first meta-analysis to summarize the association of human Hg exposure with hypertension, SBP, and DBP reported in the literature thus far. The estimates of association are based on more than 55,000 participants from 17 countries, including occupational exposures and populations exposed to Hg through diets rich in fish. The most noteworthy finding of this meta-analysis is the discrepancies in the association between Hg and blood pressure outcomes by exposure level: no or weak association from studies of populations with low-to-moderate mercury exposure and positive association among populations with high mercury exposures. The current evidence suggests a hair Hg concentration of $2–3\;\mu g/g$ as the threshold of Hg's toxic effect on blood pressure outcomes, although further study is required to confirm this value. Hair Hg concentration higher than $2\;\mu g/g$ is associated with a 59% increase in OR for hypertension, an increase of $2.20\,\text{mmHg}$ and $1.24\,\text{mmHg}$ in SBP and DBP, respectively.

As a generic method to integrate results from multiple studies, traditional meta-analysis calculates a summary estimate of the association ([@c19]). When a simple summary of association is not appropriate, subgroup meta-analysis provides useful information about patterns of the associations and their relations to study characteristics, such as the Hg species and biomarkers ([@c74]). Dose--response meta-analysis characterizes the pattern of the exposure--response relations from multiple original studies ([@c60]). In this study, we focused on the discrepancies in the association of Hg and hypertension at different exposure levels and also explored the contributions of three main factors including exposure groups, Hg species and use of biomarkers, to the heterogeneity of the association.

Apparent discrepancies in the association of hypertension with Hg exposure were observed between populations exposed to low-to-moderate and high Hg. One potential concern is that the studies reporting high exposure and the studies reporting low-to-moderate exposure were conducted in different populations ([Figure 2](#f2){ref-type="fig"}, S2, S3). Some inherent differences among these populations, e.g., lifestyle and social economic status, background prevalence of hypertension and mean BP levels, and genetic adaptation to Hg exposure may confound the association between Hg and BP. Such confounding cannot be fully ruled out, although most of the included studies adjust for these characteristics within each population to some extent. Another noteworthy phenomenon is that negative associations were reported from multiple studies conducted at low-to-moderate exposure level ([@c50]; [@c53]; [@c63]; [@c87]). This phenomenon raises three questions: (1) should we adopt a linear nonthreshold model, or a nonlinear threshold model to assess the effects of Hg on hypertension? (2) what dose should be proposed as the threshold if we adopt the latter? and (3) what is the best approach to identify the threshold? A nonlinear threshold model seems more plausible to characterize the dose--response relationship between Hg and hypertension, based on both traditional forest plots ([Figure 2](#f2){ref-type="fig"}, S2, S3) and the dose--response curve ([Figure 4](#f4){ref-type="fig"}, S10, S11). We propose hair Hg concentration at $2\,\text{to}\, 3\;\mu g/g$ as a possible threshold for the positive association because (1) there was an apparent difference between the observed associations in populations exposed below and above it and (2) cohort studies found similar threshold for other cardiovascular outcomes, e.g., heart rate variability, carotid intima-media thickness, and myocardial infarction ([@c11]; [@c86]; [@c91]). The third question is beyond the scope of this review. Future research on new effect size combining methods, for example, modifying the cumulative meta-analysis process or dose--response meta-analysis with different reference dose group, may improve the dose--response analysis and refine the threshold.

Beyond the dose, the toxic effects of Hg also depend on the exposure group and its chemical form ([@c13]). In terms of exposure group, the included studies can be classified broadly into general populations (mostly from the United States, South Korea, and multiple European countries), coastal and Indigenous population exposed to MeHg from fish and marine mammal consumption (e.g., Inuit people living in the Arctic), and occupationally exposed populations ([Figure 3](#f3){ref-type="fig"}, S4, S5). No particular pattern was observed for the general population. Mixed results were observed in the United States general population. In contrast, relatively consistent and significant effects were observed in the studied populations in South Korea ([@c20]; [@c62]), Finland ([@c15]), and other European countries ([@c29]), in which the fish and seafood consumption were higher in comparison with seafood consumption in the U.S. population. Effects observed within the exposure subgroups (i.e., coastal and Indigenous population and occupationally exposed population) were dependent on Hg exposure level (Figure S4, S5). These results suggest that exposure dose, rather than the exposure group, is a more important factor for the association.

For Hg speciation, our subgroup analyses results showed no association for the MeHg subgroup, the marginal association for the total Hg subgroup, and significant association for the inorganic Hg subgroup (Figure S6, S7). However, these results should also be interpreted very carefully because studies were categorized by the Hg species measured, but not by the major form of Hg exposed to. The participants in many of the studies that reported only total Hg were in fact exposed mainly to MeHg. Another noteworthy finding was that the association between Hg and SBP and between Hg and DBP tended to be stronger with elevated Hg levels within each subgroup. This result again suggests that Hg exposure level is the main determinant for BP, regardless of which Hg species was measured or reported.

The use of different biomarkers reported in different studies adds additional uncertainty. We investigated the influence of biomarkers on the association by comparing the results using different biomarkers in the same study (Figure S8, S9). For studies that measured Hg in both hair and blood, the results agreed with each other well because they both reflect MeHg exposure ([@c4]; [@c11]; [@c80]). These results suggest that the intrastudy variability of the impact of the choice of biomarkers on the association between Hg and blood pressure is relatively small. However, it is more challenging to estimate the interstudy variability. For example, three studies used toenail-Hg as the only exposure biomarker, and they all fell into the low-to-moderate exposure level. The two studies conducted in the United States reported a negative association ([@c50]; [@c53]), and the one conducted in Europe reported a positive association ([@c29]). Moreover, in the dose--response meta-analysis, we converted blood and toenail-Hg concentration to hair Hg concentration. The conversion of different biomarkers to hair Hg introduces an uncertainty in the dose--response meta-analysis and can affect the shape of the curve. Nevertheless, the overall trend of the relationship should remain the same.

Our subgroup analysis showed that the studies on occupationally exposed populations, reporting results on inorganic Hg and urinary Hg concentrations, had higher OR than did the other groups. These results suggest that miners exposed to elevated Hg may be at the highest risk of Hg's effects on hypertension. This result is the opposite of the results reported in two U.S. studies. Wells et al. ([@c89]) reported a positive association between hypertension and total Hg and MeHg concentrations but a negative association with inorganic Hg. Another similar study reported that SBP was positively associated with hair-Hg (which is a biomarker of MeHg exposure) and negatively associated with urinary Hg (a biomarker of inorganic Hg exposure) ([@c26]). Because both studies were conducted on the general populations with low Hg exposure, this discrepancy suggests that the effects of inorganic Hg may be determined by the exposure dose, i.e., negative effect at a low dose and positive effect at the high dose. Another possibility is that miners exposed to high Hg from occupational exposure may be more at risk to the effects of Hg on hypertension.

Fish consumption and the nutrients from fish, e.g., omega-3 fatty acids and selenium, may partially or completely offset Hg's toxic effect on cardiovascular outcomes ([@c10]; [@c52]). This possibility poses an additional challenge to estimating the effect of Hg exposure on hypertension, especially when study participants are exposed to mercury through a diet rich in fish. We adopted different strategies to ensure the most unbiased estimates were extracted. The three examples hereafter help to illustrate our strategies. In Example 1, SBP was reported to be positively associated with Hg exposure among nonfish consumers; however, SBP was negatively associated with Hg among fish consumers in the U.S. population ([@c87]). The estimates from nonfish consumers were extracted for the pooling of effect size estimates. In Example 2, OR of hypertension in the highest exposure category is smaller than that in the second highest exposure category ([@c35]; [@c53]; [@c57]; [@c63]). We extracted data from highest exposure category, except the study from our own group ([@c35]), as the fish consumption and blood selenium concentration in the highest exposure category was not comparable to the reference category. This factor also reflects the general challenge to estimate the effect of Hg exposure alone in high fish-consuming populations, because intakes of nutrients and contaminants are highly correlated ([@c40]). In Example 3, if there were apparent discrepancies between the unadjusted measures of association and measures adjusted for fish consumption or omega-3 fatty acids ([@c29]; [@c80]), we extracted the adjusted measure of association.

Fish-consumption advisories have been issued for pregnant women and women of childbearing age to avoid Hg's neurotoxic effects on the fetus ([@c21]). Moreover, women might need to choose the type of fish more wisely in comparison with men's need to choose types of fish as several studies have shown that women are more vulnerable to the effects of Hg exposure ([@c12]; [@c57]; [@c92]). The ORs of hypertension were higher among women exposed to similar Hg levels than men were exposed to in all three studies that reported estimates for men and women separately ([@c12]; [@c57]; [@c92]). This finding is more suggestive than conclusive. Further research is needed to better examine whether a sex difference exists in Hg's toxic effect on blood pressure outcomes. Hg also reduces the effectiveness of metalloenzymes by binding to metallothionein and substitutes for zinc, copper, and other trace metals ([@c8]). In experimental studies, female rats were also reported more susceptible to MeHg than were males ([@c47]; [@c76]; [@c77]).

As a meta-analysis of observational studies, there are also some inherent limitations. First, most of the studies were of cross-sectional design. Hence, we cannot rule out the possibility that the positive association observed between Hg exposure and hypertension reflects the dietary or behavior changes due to the diagnosis of hypertension (i.e., reverse causation). Second, the outcome of hypertension was not consistently defined across studies and the methods of BP measurement varied across studies. Although this meta-analysis supports a positive relationship between Hg and hypertension, the substantial heterogeneity among studies might reflect outcome misclassification and measurement discrepancies. Third, the use of multiple biomarkers across studies may introduce uncertainty to assess Hg exposure, especially for the dose--response meta-analysis. Data manipulation during the data extraction stage and biomarker conversion in the data analysis stage may introduce additional uncertainty to the pooled estimates. The lack of studies with moderate and high Hg exposure also poses a challenge to identifying the threshold. Fourth, a meta-analysis is not able to solve potential problems with confounding that could be inherent in the original studies. Inadequate adjustment for confounders could have resulted in over- or underestimation of the true association between Hg exposure and hypertension. Finally, we should acknowledge that the included studies are generally of North American, European and Asian populations; the lack of studies from other regions, especially developing countries, represents a major gap in the literature. Conducting relevant studies in these regions will be a future research priority.

Conclusions {#s5}
===========

The association between Hg exposure and the prevalence of hypertension was nonlinear, with no association in populations exposed to low-to-moderate mercury (hair Hg $< 2\;\mu g/g$) and evident association in populations exposed to high mercury (hair Hg $\geq 2\;\mu g/g$). However, the interpretation of causal association of Hg exposure and hypertension is limited by the cross-sectional design of original studies. Current evidence suggests that hair Hg concentration of $2–3\;\mu g/g$ might be considered as the threshold of Hg's toxic effect on hypertension. Heterogeneity was observed for Hg species and exposure groups across different studies. Associations estimated using different Hg biomarkers generally agree with each other in the same study. Prospective cohort studies in populations exposed to moderate and high Hg and studies in populations not yet covered by this review are needed to better characterize the relationship between Hg exposure and hypertension. Systematic review and dose--response meta-analysis of Hg exposure and other cardiovascular outcomes would add further evidence about Hg's toxic effect.
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Click here for additional data file.
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